Stool-based tests for colorectal cancer (CRC) screening show no significant difference in detecting advanced neoplasia overall, but for advanced serrated lesions specifically, the multitarget stool ...

What if you didn't have to get a colonoscopy every decade from ages 45 to 75? No, this isn't an excuse to skip screening for colon cancer, which has been proven to save lives. But there are several ...

March marks the beginning of Colorectal Cancer Awareness Month. At-home stool tests can be an easier way to screen for colorectal cancer than a dreaded colonoscopy. As the rates of the cancer continue ...

Please provide your email address to receive an email when new articles are posted on . The multitarget stool DNA test had a positive predictive value of 31.4% for detecting advanced adenomas.

Noninvasive surveillance with multitarget stool DNA testing or fecal immunochemical testing (FIT) could potentially match colonoscopy for reducing long-term colorectal cancer (CRC) incidence and ...

Annual fecal immunochemical test-based surveillance could be as effective as colonoscopies in reducing long-term colorectal cancer incidence and mortality, according to a recent study published in ...

A test that rapidly detects signs of inflammatory bowel disease (IBD) in stool samples could improve future diagnosis and ...

Stool-based DNA testing can help bridge CRC screening gaps between rural and urban populations by providing timely follow-up. The study found no significant difference in follow-up times for ...

A colonoscopy is recommended every decade for people over 45. The screening is used to detect colon cancer. But roughly 40% of eligible Americans don't get a colonoscopy, often because they don't want ...